[Back By Popular Demand] “Set It And Forget It” Catalyst Trading

Dear Undefined, Right about now — you’re probably trying to put the pieces of the puzzle together and figure out the impact the election will have on the overall market. If you are tired of all this uncertainty and feel as if you’re one step behind — then listen up because I believe I have the perfect solution… A Buy And Hold Strategy Stop right there — I already know what you’re thinking… “Kyle are you serious right now? Given this market environment, how in the world can you say a buy and hold strategy can help improve trading performance?” Just give me one minute of your time, and I’ll show you the money-making potential buy and hold has to offer… Not only that, but I’ll put to bed the argument that buy and hold is dead. The way I buy and hold is very different from anyone I’ve ever seen before. I’m not buying and holding market exchange-traded funds (ETFs) such as SPY, QQQ, DIA, and IWM. Nor am I targeting sector ETFs or just buying stocks because everyone and their brother are in them. Not only that, but the buy and hold strategy I use to rake in gains from the market doesn’t require me to hold on for years and reap the rewards later. You see, the strategy I utilize involves “long-term” catalyst events — and catalyst trades just so happen to be my bread-and-butter. The ability to identify catalysts has allowed me to generate more than $4M in trading gains in just 10 months.* If you want to capitalize on this trading style, I believe it’s important to learn how to trade “long-term” catalysts first. [I know you probably want in on this strategy](, but first I want to tell you what Sniper Report — my “buy and hold” strategy — is all about. Take this Opko Health (OPK) catalyst trade for example.* I identified long-term catalysts in OPK, as shown above. I developed a plan and executed, I did all the research I could possibly do and all I had to do was remain patient after. In just a matter of one month, I was able to lock in 87.5% on the trade.* Of course, not all of my catalyst plays are winners. However, more often than not they are… otherwise I wouldn’t be trading this strategy anymore.* With my actionable trade ideas, I’m able to teach traders how to take advantage of “long-term” catalyst plays… And some have even learned to take these ideas and make them their own.** **RagingBull does NOT track or verify subscribers' individual trading results and these individual experiences should NOT be understood as typical as or representative. Please see our full disclaimer here: ragingbull.com/disclaimer Listen, I’m not showing you this to brag… I just want to show you what’s possible if you learn the right “buy and hold” strategy. In this market environment, I expect there to be plenty of catalyst plays out there and it will take time for them to develop — [you better believe I’ll use]([Sniper Report]([to snipe these money-makers.]( Since I believe now is the best time to trade “long-term” catalysts, I’ve decided to destroy the barrier of entry to Sniper Report. Normally, Sniper Report goes for $997, but you can gain annual access for a fraction of that. [For a limited time only, you can get]([Sniper Report]([for only $49.]( You DID NOT read that wrong. You can gain annual access to Sniper Report for less than $1 per week. This no-brainer deal won’t be around for long, and I’m only letting a select group of people in. [As we all know, a deal this enticing won’t be around for long.]( Why risk paying $997, when you can pay less than $1 per week for Sniper? [Join]([Sniper Report]([now]([.]( Kyle Dennis *Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.